Head-To-Head Contrast: Encompass Health (NYSE:EHC) & Centene (NYSE:CNC)

by · The Cerbat Gem

Encompass Health (NYSE:EHC – Get Free Report) and Centene (NYSE:CNC – Get Free Report) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

Earnings & Valuation

This table compares Encompass Health and Centene”s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Encompass Health$5.94 billion2.13$566.20 million$6.1420.84
Centene$202.94 billion0.17-$6.67 billion($10.44)-6.76

Encompass Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Encompass Health and Centene’s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Encompass Health10.01%18.08%8.22%
Centene-2.51%12.12%3.20%

Volatility & Risk

Encompass Health has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Centene has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Encompass Health and Centene, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Encompass Health01513.00
Centene210902.33

Encompass Health presently has a consensus price target of $148.50, indicating a potential upside of 16.03%. Centene has a consensus price target of $70.05, indicating a potential downside of 0.80%. Given Encompass Health’s stronger consensus rating and higher probable upside, research analysts clearly believe Encompass Health is more favorable than Centene.

Institutional and Insider Ownership

97.3% of Encompass Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 1.8% of Encompass Health shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Encompass Health beats Centene on 12 of the 15 factors compared between the two stocks.

About Encompass Health

(Get Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

About Centene

(Get Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.